BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11083647)

  • 41. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
    Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
    J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
    Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
    Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
    Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines.
    Cheng Z; Zhi X; Sun G; Guo W; Huang Y; Sun W; Tian X; Zhao F; Hu K
    J Med Virol; 2016 Apr; 88(4):653-63. PubMed ID: 26331371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
    King RW; Ladner SK; Miller TJ; Zaifert K; Perni RB; Conway SC; Otto MJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3179-86. PubMed ID: 9835512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
    Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
    Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.
    Li Y; Fu L; Yeo H; Zhu JL; Chou CK; Kou YH; Yeh SF; Gullen E; Austin D; Cheng YC
    Antivir Chem Chemother; 2005; 16(3):193-201. PubMed ID: 16004082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.
    Iyer RP; Jin Y; Roland A; Morrey JD; Mounir S; Korba B
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2199-205. PubMed ID: 15155222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
    Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
    J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient.
    Zhang Q; Chen J; Pan M; Liu J; Liu T; Zhou YH
    Virus Res; 2018 Aug; 255():165-170. PubMed ID: 30075160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
    Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
    J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
    Cao H; Tao P
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(16):1004-7. PubMed ID: 11718074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
    Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
    World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
    Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
    Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.
    Karatayli E; Karatayli SC; Cinar K; Gokahmetoglu S; Güven K; Idilman R; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2012 Feb; 53(2):130-4. PubMed ID: 22078148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.